DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer-Reference-Cited by-同舟云学术

DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer

Published:2022-09-08 Issue:1 Volume:25 Page:218-225
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Li Yuan,Liao Leen^ORCID,Kong Lingheng,Jiang Wu,Tang Jinghua,Han Kai,Hou Zhenlin,Zhang Chenzhi,Zhou Chi,Zhang Linjie,Sui Qiaoqi,Xiao Binyi,Mei Weijian,Xu Yanbo,Yu Jiehai,Hong Zhigang,Pan Zhizhong,Ding Peirong

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-022-02930-8.pdf

Reference25 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. https://doi.org/10.3322/caac.21551.

2. Chen W, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32. https://doi.org/10.3322/caac.21338.

3. Benson AB, et al. NCCN Guidelines Insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018;16:359–69. https://doi.org/10.6004/jnccn.2018.0021.

4. Des Guetz G, Uzzan B, Morere JF, Perret G, Nicolas P. Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD007046.pub2.

5. Grothey A, et al. Duration of adjuvant chemotherapy for stage III colon cancer. N Engl J Med. 2018;378:1177–88. https://doi.org/10.1056/NEJMoa1713709.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer;Therapeutic Advances in Medical Oncology;2024-01